Additional information
| Trade Name | Nublexa |
|---|---|
| Generic Name | Regorafenib |
| Manufacturer | Bayer Zydus plc |
| Drug Type | Oncology |
| Indication | Colorectal, Liver Cancer |
| Doasage Form | Tablet |
| Packaging | 28 Film coated Tablets / pack |
NUBLEXA (Regorafenib)-40 mg
NUBLEXA (Regorafenib) is a multikinase inhibitor (MKI) that targets cancer growth and progression by inhibiting multiple protein kinases to improve survival in patients.
It is used to treat cancer of the colon and rectum. It is also used to treat liver cancer and a certain cancer of the digestive system (gastrointestinal stromal tumor- GIST)
